Recent research uncovers strong correlations between gut bacteria composition and physical function in seniors, suggesting microbiome-targeted interventions could combat frailty. Can the bacteria in y...
Senolytics like dasatinib and quercetin are transforming dermatology from cosmetic fixes to true biological rejuvenation, with recent trials showing improved skin elasticity and potential for treating...
A comparative study reveals that dasatinib-quercetin reduces senescence and fibrosis in intervertebral disc degeneration, while navitoclax shows no benefit, highlighting DQ’s potential for affor...
New research links exercise-induced gut microbiome changes to better physical function in seniors, suggesting personalized probiotics could enhance healthy aging. Regular moderate activity boosts bene...
Dermatology is shifting from surface-level cosmetics to biology-driven interventions targeting aging hallmarks, with senolytics, epigenetic reprogramming, and biomimetic peptides leading the charge. D...
Large animals like whales and elephants have evolved superior DNA repair and cancer suppression mechanisms, offering insights for human aging and disease prevention. New studies reveal how massive mam...
A March 2025 study shows mild acidosis increases frailty risk by 40% in seniors with normal kidney function, pointing to dietary interventions and alkali supplementation. A March 2025 study found low ...
New single-cell studies reveal distinct immune aging trajectories in women and men, with implications for personalized vaccines, autoimmune monitoring, and cancer screening. The immune system ages dif...
A 2023 study in the Journal of Cachexia, Sarcopenia and Muscle finds rapamycin reduces muscle protein synthesis after exercise in older adults, highlighting trade-offs in longevity strategies. Recent ...
Phase 1 data for BGE-102 demonstrates significant reductions in hsCRP and inflammatory biomarkers, positioning it as a potential best-in-class therapy for cardiovascular risk and age-related inflammat...
